SeventhBiz
Trending now
Tariffs Labor Costs Platform Consolidation AI Workforce Automation Interest Rates Data Center Load AI Capex IRA Incentives FDA Approval Pathway Agentic AI

Companies · HIMS

HIMS Reported this cycle

Hims & Hers

San Francisco, CA Founded 2017 Healthcare Technology

AI-generated · informational only · not investment advice · verify before relying.

Latest analysis

Updated Oct 7, 2026

Hims & Hers appoints Jonathan Franklin as chief accounting officer following Becklund transition

Hims & Hers completed a planned transition in its principal accounting officer role on October 9, 2026, with Jonathan Franklin, a former Rivian corporate controller with PwC experience, assuming the position. Franklin's $425,000 base salary, $150,000 signing bonus, and $3 million equity grant reflect the company's investment in financial leadership amid rapid scale. Outgoing principal accounting officer Irene Becklund transitioned to an advisory role through July 2027.

Tone: neutral

Revenue

$2.3B

HIMS 10-K · FY 2025

Employees

2,442

Revenue growth YoY

+59%

Founded

2017

Profile

HIMS 10-K Item 1 · Feb 23, 2026

Hims & Hers is a consumer-first digital health and wellness platform that connects patients to licensed healthcare providers via telehealth, fulfills prescriptions through its own licensed pharmacies, and sells prescription and non-prescription products via subscription. The company operates across sexual health, hair loss, hormone health, weight loss, dermatology, and mental health, serving customers in the United States, Canada, the United Kingdom, and the European Union. Its integrated model spans provider network, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities.

Read filing description ↓

Hims & Hers Health, Inc. has built a consumer-first platform transforming the way customers fulfill their health and wellness needs. We believe that the Company has the technical infrastructure, distributed provider network, and access to clinical capabilities to lead the migration of routine office visits to a personalized, digital, accessible format. The Hims & Hers platforms include access to a highly-qualified and technologically-innovative provider network, an electronic medical record system designed to support providers and customers, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Our digital platform enables access to treatments for a broad range of chronic conditions, including those related to sexual health, hair loss, hormone health, weight loss, dermatology, and mental health, as well as services such as comprehensive laboratory testing. Hims & Hers connects patients to licensed healthcare professionals who can prescribe medications when appropriate, including through personalized treatment plans, with prescriptions fulfilled online through licensed pharmacies. In addition, we also offer access to a range of non-prescription health and wellness products. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services that promote lifelong health and wellness. Since our founding, we have facilitated over fifty million telehealth consultations, enabling greater access to high-quality, convenient, affordable, personalized care for people in the United States, Canada, the United Kingdom, and the European Union.

Primary products

  • Prescription medications (generic, brand-name, and compounded)
  • Compounded GLP-1 products
  • Over-the-counter drug and device products
  • Cosmetics and supplement products
  • Telehealth consultations
  • Laboratory testing services

End markets

Sexual health Hair loss Hormone health Weight loss Dermatology Mental health Laboratory testing

Geographies

United States Canada United Kingdom European Union

Named customers

Ochsner Health Mount Sinai Health System Carbon Health ChristianaCare Health System Hartford Healthcare Asda Stores Limited Superdrug Stores PLC
“While we believe there are currently no direct competitors that offer the full suite of solutions and direct-to-consumer touch points as we do, there are several companies that offer components of telehealth or address conditions that compete with our solutions.” Competitive position, as stated in the filing

Revenue commentary · FY 2025

Revenue increased $871.1 million, or 59%, in 2025 versus 2024, driven primarily by growth in weight loss offerings and the addition of new subscribers.

The rest of HIMS is for subscribers

Analysis, signals, diligence answers, M&A activity and every quote, each citing the filing it came from.

SeventhBiz analysis 5 signals 9 diligence answers 7 M&A transactions SWOT